Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma

Other illness

• Coexistent amyloidosis, POEMS syndrome will not be approached
• Psychiatric or other clinical conditions that preclude study compliance

Age

• If participant is of child-bearing age they cannot be pregnant, planning to come pregnant or lactating during the study period

Other

• Fully adherent to the ACS nutrition and physical activity guidelines
• On another interventional clinical trial that precludes co-enrollment
• Other important medical or safety considerations at the discretion of the investigator(s) and/or approving clinician

• Adult (≥ 18 years)
• Diagnosed with MM at least one year prior to study enrollment
• 100 days post transplant (if applicable)
• Has access to a smart phone or device with internet access
• Be deemed "clinically stable" by their physician guided by the following:
  • not expected to receive therapies beyond maintenance (for 100 days)
  • no new significant myeloma symptoms (e.g., fractures, spinal stability concerns) meriting changes in anti-neoplastic therapies in the next 30 days; AND
  • stable performance status (ECOG 0-2) assessed in the last 3 months
• No reports of severe pain \> Grade 3 \[defined by the NCI CTCAE as tumor, neurologic, bone, or other pain interfering with self-care ADLs (bathing, dressing, toileting, continence, feeding)\].
• Able to participate in PA and strength training per clinician approval and confirmed by participant
• Able to understand and willing to sign a written informed consent document
• English proficient for reading and writing